Literature DB >> 241760

Cutaneous immediate hypersensitivity in man: effects of systemically administered adrenergic drugs.

J A Kram, H R Bourne, H I Maibach, K L Melmon.   

Abstract

In in vitro models of hypersensitivity, beta adrenergic drugs inhibit the antigen-induced release of histamine and other mediators from mast cells and basophils. Epinephrine, an agent with both beta and alpha adrenergic properties, is clinically useful for treating immediate hypersensitivity reactions. We examined the effects of intravenously administered adrenergic drugs on cutaneous wheal-and-flare reactions to antigens and histamine in 7 normal men. Both epinephrine and isoproterenol, a beta agonist, inhibited skin reactions produced by antigen or histamine. Phenylephrine, an alpha adrenergic agonist, produced no effect. These results suggest that epinephrine's inhibition of cutaneous immediate hypersensitivity in vivo is mediated by beta, rather than alpha, receptors. This inhibitory effect in vivo is probably not mediated solely in preventing allergic release of inflammatory mediators since the skin reactions to histamine were inhibited as well.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 241760     DOI: 10.1016/0091-6749(75)90132-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

Review 1.  Diagnostic methods to demonstrate igE antibodies: skin testing techniques.

Authors:  W T Kniker; S W Hales; L K Lee
Journal:  Bull N Y Acad Med       Date:  1981-09

Review 2.  Auto-modulation of release of pharmacological mediators of immediate (type I) hypersensitivity. A review.

Authors:  M C Holroyde; J F Burka; P Eyre
Journal:  Agents Actions       Date:  1977-10

3.  Importance of beta 2-adrenoceptor stimulation in the suppression of intradermal antigen challenge by adrenaline.

Authors:  J B Warren; F J Pixley; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.